We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

XBP:NASDAQXBP Global Holdings, Inc. Analysis

Data as of 2026-09-08 - not real-time

$2.91

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind XBP Global Holdings, Inc. is neutral at $2.91, with no clear ordering between short and long averages. The last 30 days have lost 16.6%. RSI sits at 50.1, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $2.06 up to resistance at $3.27.
On valuation the read is undervalued — earnings multiple of 1.3 versus a 33.3 sector average, below the peer group. Consensus targets land 71.8% above where the shares trade now. Revenue is growing at 4.7% on a 134.9% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 83.8%, a beta of 1.08 and a maximum drawdown of 83.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top Market Events

FRANKFURT, Germany, Dec. 11, 2025 GLOBE NEWSWIRE -- XBP Global Holdings, Inc. “XBP Global” or “the Company”...IRVING, Texas, Feb. 25, 2026 GLOBE NEWSWIRE -- XBP Global Holdings, Inc. “XBP Global” or “the Company” NASDAQ:...IRVING, Texas, Aug. 13, 2026 GLOBE NEWSWIRE -- XBP Global Holdings, Inc. “XBP Global” or “the Company” NASDAQ:...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 4.49
  • MACD momentum is positive
  • 30-day price change of -16.6%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 1.3 versus sector average of 33.3
  • Trading below the 200-day average of 4.49
  • Analyst targets imply +71.8% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 1.3 versus sector average of 33.3
  • Analyst targets imply +71.8% versus the current price
  • Profit margin of 134.9% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth4.70%
Profit Margin134.89%
P/E Ratio1.3
ROE11938.48%
ROA-3.27%
Debt/Equity884.08
P/B Ratio0.5
Op. Cash Flow$-81033000
Free Cash Flow$76.3M
Industry P/E33.3

Technical Analysis

TrendNeutral
RSI50.1
Support$2.06
Resistance$3.27
MA 20$2.89
MA 50$2.83
MA 200$4.49
MACDBullish
VolumeIncreasing
Fear & Greed Index94.11

Valuation

Fair Value$66.41
Target Price$5.00
Upside/Downside71.82%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.08
Volatility83.84%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.